Carboplatin/Pembrolizumab/PemetrexedAcquired drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2030卷 / 1期

关键词：

D O I：

10.1007/s40278-024-68920-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：119 / 119

相关论文

共 50 条

[1] Carboplatin/pembrolizumab/pemetrexedAcquired drug resistance
Reactions Weekly, 2024, 2003 (1) : 226 - 226
[2] Crizotinib/pemetrexedAcquired drug resistance and neutropenia: case report
Reactions Weekly, 2015, 1555 (1) : 66 - 66
[3] Alectinib/pemetrexedAcquired drug resistance and lack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 27 - 27
[4] Icotinib/nedaplatin/pemetrexedAcquired drug resistance, nausea and vomiting: case report
Reactions Weekly, 2020, 1811 (1) : 145 - 145
[5] Carboplatin/trastuzumabAcquired drug resistance: case report
Reactions Weekly, 2020, 1785 (1) : 138 - 138
[6] Carboplatin/paclitaxel/pembrolizumabMyelosuppression, thrombocytopenia and acquired pembrolizumab resistance: case report
Reactions Weekly, 2020, 1810 (1) : 65 - 65
[7] Carboplatin/pembrolizumab/pemetrexedColitis: case report
Reactions Weekly, 2020, 1806 (1) : 76 - 76
[8] Carboplatin/pembrolizumab/pemetrexedEnteritis: case report
Reactions Weekly, 2021, 1843 (1) : 96 - 96
[9] Osimertinib/pemetrexedAcquired resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1926 (1) : 382 - 382
[10] Cabazitaxel/carboplatin/enzalutamideDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1800 (1) : 89 - 89

← 1 2 3 4 5 →